KA
CL icon

Kozak & Associates’s Colgate-Palmolive CL Stock Holding History

Kozak & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472 Sell
5
-56
-92% -$4.9K ﹤0.01% 402
2026
Q1 		$5.1K Buy
61
+1
+2% +$89 ﹤0.01% 308
2025
Q4 		$4.92K Hold
60
– – ﹤0.01% 307
2025
Q3 		$4.76K Buy
+60
New +$5.12K ﹤0.01% 314
2025
Q2 		– Sell
-67
Closed -$6.36K – 478
2025
Q1 		$6.36K Buy
+67
New +$6K ﹤0.01% 261
2024
Q4 		– Sell
-34
Closed -$3.44K – 444
2024
Q3 		$3.44K Buy
+34
New +$3.46K ﹤0.01% 302

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Kozak & Associates's CL Position: Q2 2026 in Review

Kozak & Associates reduced its Colgate-Palmolive (CL) stake by 92% in Q2 2026, selling an estimated $4.9K and leaving 5 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Kozak & Associates first reported a position in CL in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.36K in Q1 2025. 692 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Kozak & Associates held 5 shares of Colgate-Palmolive worth $472 as of Q2 2026.
  • Kozak & Associates sold 56 Colgate-Palmolive shares in Q2 2026, an estimated $4.9K.
  • Colgate-Palmolive made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #402 holding.
  • Kozak & Associates first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 6 quarters since.
  • Kozak & Associates's Colgate-Palmolive position peaked at $6.36K in Q1 2025.
  • 692 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.